We are GoLden!

Excellent

Exactly, progressing nicely and getting closer.

Wrong

Time to load… .58-.62 accumulation.

Let’s not forget Regeneron ($REGN) they have partnered w/ Sanofi - $900 million to gain global rights to the companies’ cancer immunotherapy “Libtayo” and now they are focused on combination drug immunotherapies.

They were at NYAS for Dr. Mulholland presentation, so partnering or buying out NWBO will make them be a formidable competitor of Merck and with dcvax platform can eventually be the global oncology leader! Oh PS… they also have Kevin Duffy ;)

NFT is huge, DIN’t be a Fool… Load up on these fire sale! ??

Well then it can be thrown out.. frivilous.

By!

We are the only winner in this Immunotherapy space! Thanks to LP & Dr Liau!!! Oh, and MRK eventually.

Oooh, TKO on the 1st round :) by!

Agree, 1000%

$1.23 now, LET’s GO!

I think we will $1.23 will be nice.

Let’s go… it’s TIME!

If no pr tomorrow June 30th this will collapse the shorts are ruthless!

illogical thinking

Thank you BB!

Yes they tried with all their might and we survived. Publication and UK regulatory approval coming. Nothing gonna stop NWBO, Go LP!

Excellent, i’m also in contact with him outstanding guy.

Hahaha, exactly… sneaky.

Do u think his trillionaires friends are going to invest on nwbo soon? Like now?

Superb!

Excellent.

Lol, good one ;)

Blah blah… whiner!

Don’t be afraid.

This news is as good as Dr. Ashkan ASCO presentation! UK wants this aprroved asap!

You better stop thinking, and too much opinions isn’t good.

So Very nice, well said.

FOMO starting tomorrow! Great P3 results, publication any day now, manufacturing ready, regulatory submission, combo trials set and etc.. etc…

Well said! ??BOOM will have whales buying in tomorrow!

Could you please list or bullet point the fraud right now for all of us to read. Thank you!

Exactly right! $MRK need to act fast or else $REGN will scoop us up! We are worth $20-$25 and after approval $50+

Excellent!!! Great great news.

Ooh the frustrations, the neg emotions all self-inflicted are oozing and taking it’s toll on peeps. Know what you hold, eye on the prize.

Hehehe nice! Agree on that, we stay tuned big weekend for us. EYE on the prize

Dcvax-L is the new sheriff in town, Chemo is dead.

Agree on valuation, plus Merck can’t afford not to get aggressive on their bo offer because there 4 other big pharma’s (BMY/PFZ/REGN/RHBBY) circling around NWBO.

Exactly, and here is something INTERESTING. - Just reading an article dated April 19, 2022 that REGN reconsidering acquisition of Checkmate (immunotherapy company with a promising immunotherapy cancer drug)… Why buyout a promising cancer drug when our dcvax-L top line data met primary and secondary endpoints!

Kevin Duffy is with REGN now and they sent a delegation of 14 employees (the most) to our presentation (4 scientists and 3 research specialists). Hmmmm…

https://www.biopharmadive.com/news/regeneron-checkmate-cancer-drug-first-acquisition/622306/